Showing 12,281 - 12,300 results of 46,280 for search '(( 50 ((we decrease) OR (a decrease)) ) OR ( 5 ((nm decrease) OR (mean decrease)) ))', query time: 1.25s Refine Results
  1. 12281

    Effect of BXL-01-0029 on IFNγ+TNFα-induced class I and class II HLA in Hfsmc. by Luigi Di Luigi (478292)

    Published 2013
    “…The simultaneous incubation with BXL-01-0029 significantly decreased the number of class II HLA-stained cells after 24 h (27.51±5.81%, <sup>#</sup>P<0.05 vs. cytokine-treated cells) and 48 h (23.54±3.31%, <sup>##</sup>P<0.01 vs. cytokine-treated cells). …”
  2. 12282

    Comparison of glomerular tuft abnormalities in E16.5 CXCR7 and CXCR4 knockout mice. by Sammy Haege (144953)

    Published 2012
    “…<p>(<b>A</b>,<b>B</b>) Immunostainings of the CXCR4 protein in an E16.5 wildtype and a CXCR7 deficient littermate show decreased CXCR4-immunoreactivity in the glomerular tuft of the CXCR7 mutant (glomerular tufts are encircled). …”
  3. 12283

    Analysis of dLGN reduction and <i>ephrin A5</i> expression in control and enucleated brains. by Olga O. Kozanian (811729)

    Published 2015
    “…(C) Area of <i>ephrin A5</i> expression in P1 dLGN. <i>Ephrin A5</i> expression within the dLGN of enucleated animals (78.98 ± 5.723%; <i>P</i> < 0.05) is significantly different than controls. …”
  4. 12284

    The <i>FZD5-GCM1</i> signaling axis is operative during human trophoblast syncytialization. by Jinhua Lu (267804)

    Published 2013
    “…(B) Expression of <i>GCM1</i> and <i>Syncytin1</i> detected by quantitative RT-PCR was down-regulated in BeWo cells upon <i>FZD5</i> knockdown. Values are normalized by GAPDH expression level and indicated as mean±SEM. …”
  5. 12285
  6. 12286

    BCL11A expression was negatively regulated by hsa-miR-190b-5p. by Meihuan Chen (15456926)

    Published 2023
    “…(C) hsa-miR-190b-5p expression was decreased in 293T cells by hsa-miR-190b-5p inhibitors. …”
  7. 12287
  8. 12288
  9. 12289

    L5 E-stimulation in S1 does not modulate sensory responses in S2 when POm is inactivated. by Carlos Castejon (2182382)

    Published 2016
    “…The experimental manipulation of the barrel cortex and POm is also shown. (B) Change (%) in mean S2 sensory response magnitude by stimulating L5 of S1 before (black) and after POm muscimol inactivation (gray). …”
  10. 12290
  11. 12291

    Analysis of 5-HT release and signaling pathways in ADORA2B-deficient rat EC cells. by Rikard Damen (407681)

    Published 2013
    “…Antisense reduced hypoxic-mediated responses (compared to controls) and ameliorated cell responses to NECA and MRS1754. <b>5C)</b> Western blot identified decreased pMAPK (0.56±0.09), pCREB (0.75±0.11) and pTPH-1 (0.63±0.07) in antisense treated cells confirming down-regulation of these pathways with loss of ADORA2B expression under hypoxic conditions. …”
  12. 12292
  13. 12293
  14. 12294
  15. 12295
  16. 12296

    Photoacoustic Tomography of Human Hepatic Malignancies Using Intraoperative Indocyanine Green Fluorescence Imaging by Akinori Miyata (656507)

    Published 2014
    “…Intraoperatively, photoacoustic tomography was performed on the surface of the resected hepatic specimens (n = 10) under excitation with an 800 nm pulse laser. In 4 hepatocellular carcinoma nodules, photoacoustic imaging identified indocyanine green accumulation in the cancerous tissue. …”
  17. 12297
  18. 12298

    AMPK activity and cell proliferation in HCC cell lines, PLC/PRF/5 and HepG2. by Jidong Cheng (548009)

    Published 2014
    “…Representative DNA histograms for PLC/PRF5 cells are shown. Data from three independent experiments are shown as mean ± SD. …”
  19. 12299
  20. 12300

    ApoA-I inhibits leukocyte adhesion to endothelial cells <i>in vivo</i>. by Scott J. Cameron (838315)

    Published 2015
    “…(B) ApoA-I knockout mice (apoA-I <sup>-/-</sup>) have low plasma HDL concentration compared to WT mice and show increased adhesion of leukocytes to the vascular endothelium <i>in vivo</i> (decreased rolling velocity) compared to WT mice or apoA-I <sup>-/-</sup> mice injected with apo-AI (0.5mg, intraperitoneal) 24 hours before. …”